Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection

Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection

Bibliographic Details
Main Authors:	Jingwei Bian, Rongsheng Zhao, Suodi Zhai, Zijian Li
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	Acta Pharmaceutica Sinica B
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383520305566

Similar Items

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021-01-01)

Reply to Letter to the Editor: 'How Does SARS-CoV-2 Fragment the QRS?'
by: Ibrahim Halil Özdemir, et al.
Published: (2022-06-01)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
by: Walaa A. Kamel, et al.
Published: (2021-09-01)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
by: Kai Chieh Chang
Published: (2021-03-01)

Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
by: Josef Finsterer
Published: (2023-07-01)

Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection
by: Valentina Giardini, et al.
Published: (2021-11-01)

Discrepancy in Screening Performances of Different Rapid Test Kits for SARS-CoV-2; a Letter to Editor
by: Phee Kheng Cheah, et al.
Published: (2020-12-01)

Designing Inhibitors for the SARS CoV Main Protease as Anti-SARS Drugs
by: Hamza Bari, et al.
Published: (2020-12-01)

Letter to the Editor Regarding "Evaluation of SARS-CoV-2 Specific Antibodies in Recovered Patients by Different ELISA Kits"
by: Nitin Deshpande
Published: (2023-12-01)

Response to the letter to the editor: two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
by: Hayri Bostan, et al.
Published: (2022-11-01)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022-04-01)

Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System
by: Farideh Zafari Zangeneh
Published: (2022-02-01)

Performance comparison between Elecsys Anti-SARS-CoV-2 and Anti-SARS-CoV-2 S and Atellica IM SARS-CoV-2 Total and SARS-CoV-2 IgG assays
by: Seri Jeong, et al.
Published: (2022-06-01)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022-11-01)

Reply to letter to the editor by Lippi and Plebani: « The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization » (THEIJID-D-22-00085)
by: Saba Gargouri, et al.
Published: (2022-04-01)

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022-06-01)

Response to the Letter to the Editor Regarding “Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021”
by: Takahiro Sanada, et al.
Published: (2023-02-01)

Letter to the Editor: Can the seasonal influenza vaccine for 2019/2020 have cross reactivity with some of the SARS-CoV-2 proteins?
by: Milad Zandi, et al.
Published: (2021-09-01)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020-09-01)

A Response Letter to: Letter to the Editor Regarding “Anti-SARS-CoV-2 Vaccination Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome: Facts and Challenges During COVID-19 Pandemic”
by: S. Duong-Quy
Published: (2023-07-01)

Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
by: Angela Lo, BA, et al.
Published: (2022-07-01)

Anti-SARS-CoV and Anti-cancer Effects of Emodin
by: Mohammad Hossein Ghaffari Agdam, et al.
Published: (2019-08-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
by: Gang Ye, et al.
Published: (2021-08-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
by: Rajat Goyal, et al.
Published: (2022-09-01)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
by: Ruofan Li, et al.
Published: (2022-08-01)

Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines
by: Pembe Derin Oygar, et al.
Published: (2022-11-01)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
by: Mazen Jizzini, et al.
Published: (2020-12-01)

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
by: Zhonglei Wang, et al.
Published: (2021-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
by: Huan Zhou, et al.
Published: (2021-12-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Immunomodulatory Drugs in the Management of SARS-CoV-2
by: Daniel R. Burrage, et al.
Published: (2020-08-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Dexamethasone and SARS-CoV-2: the Dangerous Steroids Pandemic (Letter to the Editorial Office)
by: A. Belletti, et al.
Published: (2022-02-01)

Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
by: Luis C. Vesga, et al.
Published: (2022-04-01)

“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
by: Mascellino MT, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Reply to the Letter to the Editor Titled “Neuroimaging Abnormalities in SARS-CoV-2 Infected are More Diverse than Previously Thought and Depend on the Methods Used”
by: Sarbesh Tiwari, et al.
Published: (2024-04-01)